Horizons in Cancer Research. Volume 54

Authors:

Hiroto S Watanabe

Brand: Nova Science Publishers Inc

ISBN: 9781633213890

1,140.24 zł

1,026.21 zł Save 114.03 zł Tax included

Lowest price within 30 days before promotion: 1,026.21 zł

Quantity

Available in 4-6 weeks

Delivery policy

Choose Paczkomat Inpost, Orlen Paczka, DPD or Poczta Polska. Click for more details

Security policy

Pay with a quick bank transfer, payment card or cash on delivery. Click for more details

Return policy

If you are a consumer, you can return the goods within 14 days. Click for more details

Description

This book presents original results on the leading edge of cancer research. Topics discussed include the risk factors, diagnosis and treatment options for glioblastoma; the biology of the interleukin-2 (il-2)-based immunotherapies in cancer and autoimmune disease; rna interference (rnai)/rna activation (rnaa) for cancer therapeutics; melanoma progression to metastatic disease; proteins, polysaccharide-peptide complexes and polysaccharides with antiproliferative and anticancer activities of mushrooms; low-molecular-weight compounds with anticancer activity of mushroom origin; lifestyle and cancer prevention; and the pathology and pathogenesis of Hodgkins lymphoma.

Product Details

Brand Nova Science Publishers Inc

Reference 74632

EAN13 9781633213890

ISBN 9781633213890

Data sheet

Publication date: 2014
Issue number: 1
Cover: hard cover
Pages count: 227
Dimensions (mm): 178.00 x 254.00
Weight (g): 556

PrefaceGlioblastoma:: Risk Factors, Diagnosis and Treatment Options(André Ballesteros-Tato, Troy D. Randall, Department of Medicine, Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL, USA)The Biology of the Interleukin-2 (IL-2)-Based Immunotherapies in Cancer and Autoimmune Disease(André Ballesteros-Tato, Troy D. Randall, Department of Medicine, Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL, USA)OFF or ON:: RNA Interference (RNAi) / RNA Activation (RNAa) for Cancer Therapeutics(Sorah Yoon, John J. Rossi, Department of Molecular and Cellular Biology, Beckman Research, Institute of City of Hope, Duarte, California, USA)Melanoma Progression to Metastatic Disease:: The Role of the PI3K/AKT and Wnt/β-Catenin Pathways(Jaskiran Sidhu, Geetha Venkateswaran, Sujata Persad, Department of Pediatrics Faculty of Medicine and Dentistry University of Alberta, Edmonton, Alberta, Canada)For Complete Table of Contents, please visit our website athttps:://www.novapublishers.com/catalog/product_info.php?cPath=23_29&products_id=50487

Comments (0)

Frequently purchased together

No products available

Cookie name	Provider	Purpose	Expiry
cookiesplus	https://medbook.com.pl	Stores your cookie preferences.	1 year
PHP_SESSID	https://medbook.com.pl	This cookie is native to PHP and enables websites to store serialised state data. It is used to establish a user session and to pass state data via a temporary cookie, which is commonly referred to as a session cookie.	Session
PrestaShop-#	https://medbook.com.pl	This cookie helps keep user sessions open while they are visiting a website, and help them make orders and many more operations such as: cookie add date, selected language, used currency, last product category visited, last seen products, client identification, name, first name, encrypted password, email linked to the account, shopping cart identification.	480 hours

Cookie name	Provider	Purpose	Expiry
fr	Facebook	Used by Facebook to deliver a series of advertisement products such as real time bidding from third party advertisers.	3 months
tr	Facebook	Used by Facebook to deliver a series of advertisement products such as real time bidding from third party advertisers.	Session
_fbp	Facebook	Used by Facebook to deliver a series of advertisement products such as real time bidding from third party advertisers.	3 months

Horizons in Cancer Research. Volume 54

Frequently purchased together